CytomX Therapeutics, Inc. announced that Frederick W. Gluck is retiring from its board of directors, effective June 30, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.485 USD | -1.66% |
|
+14.50% | -3.23% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.23% | 118M | |
+20.71% | 126B | |
+24.67% | 118B | |
+24.83% | 27.87B | |
-17.17% | 20.95B | |
-14.94% | 16.92B | |
-15.60% | 16.18B | |
+11.29% | 14.84B | |
-47.10% | 14.79B | |
+54.18% | 14.08B |
- Stock Market
- Equities
- CTMX Stock
- News CytomX Therapeutics, Inc.
- CytomX Therapeutics, Inc. Announces Retirement of Frederick W. Gluck from Board of Directors